2011
DOI: 10.1016/j.jamcollsurg.2010.09.029
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of 5α-Reductase Inhibition on Benign Prostatic Hyperplasia Treated by Photoselective Vaporization Prostatectomy with the 120 Watt GreenLight HPS Laser System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 23 publications
1
7
1
Order By: Relevance
“…Similar results were reported in a prospective study by Akari et al who demonstrated no significant difference between IPSS scores, PVR and Qmax between patients on or off 5-ARI therapy following 80 W PVP (17). Similar results were reported by Strom et al in patients undergoing 120 W PVP (16). …”
Section: Pre-operative Factorssupporting
confidence: 91%
See 1 more Smart Citation
“…Similar results were reported in a prospective study by Akari et al who demonstrated no significant difference between IPSS scores, PVR and Qmax between patients on or off 5-ARI therapy following 80 W PVP (17). Similar results were reported by Strom et al in patients undergoing 120 W PVP (16). …”
Section: Pre-operative Factorssupporting
confidence: 91%
“…Indeed, Kuntzman et al demonstrated that bloodless cadaver tissue to be less responsive to KTP laser vaporization than living canine tissue (15). Intra-operatively, Strom et al reported that six months of 5-ARI therapy prior to PVP had no effect on operative duration (31±19 vs. 32±25 mins), lasering time (13±9.2 vs. 13.4±10.3 mins) or energy used (87.1±62.4 vs. 91.8±69.7 kJ) (16). Similarly, post-operative functional data appears independent of the presence of 5-ARI therapy.…”
Section: Pre-operative Factorsmentioning
confidence: 99%
“…Prostate volume is an important parameter in diagnosis and treatment of both benign and malign prostate disease (5,6). For BPH, prostate volume is important in predicting response to 5α-reductase therapy and is also used to select which surgical treatment modality is the best for the patient (7,8). In calculating PSA density, prostate volume is used as the denominator (9).…”
Section: Introductionmentioning
confidence: 99%
“…Some reports suggested that 5-ARIs may only affect microvessel density [22,23] and vascular endothelial growth factor expression [24] at the suburethral level, but not at the hyperplastic prostate level. The 5-ARIs may have little effect on significant bleeding vessels because these drugs only decrease microvessel density in the suburethral region, with little if any effect on the deeper hyperplastic prostate tissues [25]. The grossly visible perforating creeping vessels that bleed during dissection of adenomas cannot be significantly reduced with 5-ARI use alone.…”
Section: Discussionmentioning
confidence: 99%